KC
PTLA

Kellner Capital’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Kellner Capital’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-67,800
Closed -$1.22M – 34
2020
Q2 		$1.22M Buy
+67,800
New +$943K 0.6% 17

Kellner Capital's PTLA Position: Q3 2020 in Review

Kellner Capital sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 67,800 shares — an estimated $1.22M sold.

Kellner Capital first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $1.22M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Kellner Capital reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Kellner Capital sold 67,800 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.22M.
  • Kellner Capital first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Kellner Capital's Portola Pharmaceuticals, Inc. position peaked at $1.22M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Kellner Capital's 13F filing for Q3 2020, filed 9 Nov 2020.